FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094080327> ?p ?o ?g. }

• W3094080327 abstract "Immune checkpoint inhibitors (ICIs) have shown potential to improve the prognosis of patients with brain metastasis (BM) caused by advanced cancers. However, controversies still exist in regard to its survival benefits. In the present work, a time series-based meta-analysis based on the phase I/II/III trials and observational studies were performed to investigate the differences in mortality of ICI-treated BM patients. A number of public library databases, including MEDLINE, EMBASE, OVID, and COCHRANE, were systemically searched by March 2019. The quality of included studies was evaluated by the Newcastle-Ottawa Scale (NOS) scoring. Outcome measures here established were mortality and progression-free survival (PFS) at different follow-up endpoints. Survival rates and curve data were pooled for further analysis. To detect the data heterogeneity, subgroup analyses were conducted according to tumor and ICI types. Eighteen studies, 6 trials, and 12 controlled cohorts were assessed, involving a total of 1330 ICI-treated BM patients. The 6-month survival rate and PFS were 0.67 (95%CI: 0.59-0.74) and 0.36 (95%CI: 0.24-0.49), respectively. According to the tumor type (melanoma, NSCLC, and RCC), subgroup analyses indicated that melanoma presented the lowest survival rates among the three groups here selected. In regard to the type of ICIs, the anti-CTLA-4 combined with the anti-PD-1/PD-L1 showed the best survival outcome among these groups. The 12-month survival rate and PFS showed a consistent pattern of findings. In the long-term, the 24-month survival rate and PFS were 0.20 (95%CI: 0.12-0.31) and 0.18 (0.05-0.46) in BM patients. Hence, ICI therapy may be associated with an improved prognosis of BM patients. Nevertheless, current research presented a limited study design. Multicenter randomized trials may later assist in validating ICI-based therapies for a better outcome of BM patients." @default.
• W3094080327 created "2020-10-29" @default.
• W3094080327 creator A5013014678 @default.
• W3094080327 creator A5014314263 @default.
• W3094080327 creator A5018928264 @default.
• W3094080327 creator A5024741363 @default.
• W3094080327 creator A5027440092 @default.
• W3094080327 creator A5067949841 @default.
• W3094080327 creator A5084768375 @default.
• W3094080327 date "2020-10-20" @default.
• W3094080327 modified "2023-09-26" @default.
• W3094080327 title "Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis" @default.
• W3094080327 cites W112133451 @default.
• W3094080327 cites W1979651049 @default.
• W3094080327 cites W1991598656 @default.
• W3094080327 cites W2035989812 @default.
• W3094080327 cites W2060279158 @default.
• W3094080327 cites W2067893090 @default.
• W3094080327 cites W2098677385 @default.
• W3094080327 cites W2116475791 @default.
• W3094080327 cites W2130685639 @default.
• W3094080327 cites W2133350192 @default.
• W3094080327 cites W2155073814 @default.
• W3094080327 cites W2166662937 @default.
• W3094080327 cites W2169205464 @default.
• W3094080327 cites W2183991412 @default.
• W3094080327 cites W2326574449 @default.
• W3094080327 cites W2365348826 @default.
• W3094080327 cites W2415633845 @default.
• W3094080327 cites W2416791964 @default.
• W3094080327 cites W2460924712 @default.
• W3094080327 cites W2476838381 @default.
• W3094080327 cites W2525304626 @default.
• W3094080327 cites W2572174216 @default.
• W3094080327 cites W2584204876 @default.
• W3094080327 cites W2606945601 @default.
• W3094080327 cites W2614237654 @default.
• W3094080327 cites W2736715485 @default.
• W3094080327 cites W2771966188 @default.
• W3094080327 cites W2772139593 @default.
• W3094080327 cites W2772183668 @default.
• W3094080327 cites W2791513659 @default.
• W3094080327 cites W2794627893 @default.
• W3094080327 cites W2802150163 @default.
• W3094080327 cites W2805437817 @default.
• W3094080327 cites W2805897039 @default.
• W3094080327 cites W2807965874 @default.
• W3094080327 cites W2810165177 @default.
• W3094080327 cites W2886424233 @default.
• W3094080327 cites W2888298425 @default.
• W3094080327 cites W2890381929 @default.
• W3094080327 cites W2890480472 @default.
• W3094080327 cites W2890992996 @default.
• W3094080327 cites W2896532024 @default.
• W3094080327 cites W2899201941 @default.
• W3094080327 cites W2900126305 @default.
• W3094080327 cites W2905870269 @default.
• W3094080327 cites W2908622615 @default.
• W3094080327 doi "https://doi.org/10.3389/fonc.2020.564382" @default.
• W3094080327 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7606910" @default.
• W3094080327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33194639" @default.
• W3094080327 hasPublicationYear "2020" @default.
• W3094080327 type Work @default.
• W3094080327 sameAs 3094080327 @default.
• W3094080327 citedByCount "8" @default.
• W3094080327 countsByYear W30940803272021 @default.
• W3094080327 countsByYear W30940803272022 @default.
• W3094080327 countsByYear W30940803272023 @default.
• W3094080327 crossrefType "journal-article" @default.
• W3094080327 hasAuthorship W3094080327A5013014678 @default.
• W3094080327 hasAuthorship W3094080327A5014314263 @default.
• W3094080327 hasAuthorship W3094080327A5018928264 @default.
• W3094080327 hasAuthorship W3094080327A5024741363 @default.
• W3094080327 hasAuthorship W3094080327A5027440092 @default.
• W3094080327 hasAuthorship W3094080327A5067949841 @default.
• W3094080327 hasAuthorship W3094080327A5084768375 @default.
• W3094080327 hasBestOaLocation W30940803271 @default.
• W3094080327 hasConcept C10515644 @default.
• W3094080327 hasConcept C121608353 @default.
• W3094080327 hasConcept C126322002 @default.
• W3094080327 hasConcept C143998085 @default.
• W3094080327 hasConcept C187960798 @default.
• W3094080327 hasConcept C23131810 @default.
• W3094080327 hasConcept C2776283816 @default.
• W3094080327 hasConcept C2776478404 @default.
• W3094080327 hasConcept C2777658100 @default.
• W3094080327 hasConcept C2778164965 @default.
• W3094080327 hasConcept C2779013556 @default.
• W3094080327 hasConcept C502942594 @default.
• W3094080327 hasConcept C71924100 @default.
• W3094080327 hasConcept C95190672 @default.
• W3094080327 hasConceptScore W3094080327C10515644 @default.
• W3094080327 hasConceptScore W3094080327C121608353 @default.
• W3094080327 hasConceptScore W3094080327C126322002 @default.
• W3094080327 hasConceptScore W3094080327C143998085 @default.
• W3094080327 hasConceptScore W3094080327C187960798 @default.
• W3094080327 hasConceptScore W3094080327C23131810 @default.
• W3094080327 hasConceptScore W3094080327C2776283816 @default.
• W3094080327 hasConceptScore W3094080327C2776478404 @default.
• W3094080327 hasConceptScore W3094080327C2777658100 @default.

• next